Comparison of Hospital Mortality With Intra‐Aortic Balloon Counterpulsation Insertion Before vs After Primary Percutaneous Coronary Intervention for Cardiogenic Shock Complicating Acute Myocardial Infarction
{"title":"Comparison of Hospital Mortality With Intra‐Aortic Balloon Counterpulsation Insertion Before vs After Primary Percutaneous Coronary Intervention for Cardiogenic Shock Complicating Acute Myocardial Infarction","authors":"S. Harris, D. Tepper, Randy J. Ip","doi":"10.1111/J.1751-7133.2010.00174.X","DOIUrl":null,"url":null,"abstract":"Abstract. Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump counterpulsation (IABP) are established treatment modalities in acute myocardial infarction complicated by cardiogenic shock. We hypothesized that the insertion of the IABP before primary PCI might result in better survival of patients with cardiogenic shock compared with postponing the insertion until after primary PCI. We, therefore, retrospectively studied 48 patients who had undergone primary PCI with IABP because of cardiogenic shock complicating acute myocardial infarction (26 patients received the IABP before and 22 patients after primary PCI). No significant differences were present in the baseline clinical characteristics between the 2 groups. The mean number of diseased vessels was greater in the group of patients treated with the IABP before primary PCI (2.8±0.5 vs 2.3±0.7, P=.012), but the difference in the number of treated vessels was not significant. The peak creatine kinase and creatine kinase-MB levels were lower in patients treated with the IABP before primary PCI (median, 1077; interquartile range, 438–2067 vs median, 3299; interquartile range, 695–6834; P=.047 and median, 95; interquartile range, 34–196 vs median, 192; interquartile range, 82–467; P=.048, respectively). In-hospital mortality and the overall incidence of major adverse cardiac and cerebrovascular events were significantly lower in the group of patients receiving the IABP before primary PCI (19% vs 59% and 23% vs 77%, P=.007 and P=.0004, respectively). Multivariate analysis identified renal failure (odds ratio, 15.2; 95% confidence interval, 3.13–73.66) and insertion of the IABP after PCI (odds ratio, 5.2; 95% confidence interval, 1.09–24.76) as the only independent predictors of in-hospital mortality. In conclusion, the results of the present study suggest that patients with cardiogenic shock complicating acute myocardial infarction who undergo primary PCI assisted by IABP have a more favorable in-hospital outcome and lower in-hospital mortality than patients who receive IABP after PCI. Abdel-Wahab M, Saad M, Kynast J, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2010;105:967–971.","PeriodicalId":10536,"journal":{"name":"Congestive heart failure","volume":"40 1","pages":"240-240"},"PeriodicalIF":0.0000,"publicationDate":"2010-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Congestive heart failure","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1751-7133.2010.00174.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Abstract. Primary percutaneous coronary intervention (PCI) and intra-aortic balloon pump counterpulsation (IABP) are established treatment modalities in acute myocardial infarction complicated by cardiogenic shock. We hypothesized that the insertion of the IABP before primary PCI might result in better survival of patients with cardiogenic shock compared with postponing the insertion until after primary PCI. We, therefore, retrospectively studied 48 patients who had undergone primary PCI with IABP because of cardiogenic shock complicating acute myocardial infarction (26 patients received the IABP before and 22 patients after primary PCI). No significant differences were present in the baseline clinical characteristics between the 2 groups. The mean number of diseased vessels was greater in the group of patients treated with the IABP before primary PCI (2.8±0.5 vs 2.3±0.7, P=.012), but the difference in the number of treated vessels was not significant. The peak creatine kinase and creatine kinase-MB levels were lower in patients treated with the IABP before primary PCI (median, 1077; interquartile range, 438–2067 vs median, 3299; interquartile range, 695–6834; P=.047 and median, 95; interquartile range, 34–196 vs median, 192; interquartile range, 82–467; P=.048, respectively). In-hospital mortality and the overall incidence of major adverse cardiac and cerebrovascular events were significantly lower in the group of patients receiving the IABP before primary PCI (19% vs 59% and 23% vs 77%, P=.007 and P=.0004, respectively). Multivariate analysis identified renal failure (odds ratio, 15.2; 95% confidence interval, 3.13–73.66) and insertion of the IABP after PCI (odds ratio, 5.2; 95% confidence interval, 1.09–24.76) as the only independent predictors of in-hospital mortality. In conclusion, the results of the present study suggest that patients with cardiogenic shock complicating acute myocardial infarction who undergo primary PCI assisted by IABP have a more favorable in-hospital outcome and lower in-hospital mortality than patients who receive IABP after PCI. Abdel-Wahab M, Saad M, Kynast J, et al. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 2010;105:967–971.
摘要原发性经皮冠状动脉介入治疗(PCI)和主动脉内球囊泵反搏(IABP)是急性心肌梗死并发心源性休克的常用治疗方法。我们假设在初次PCI前插入IABP可能比推迟到初次PCI后插入IABP更能提高心源性休克患者的生存率。因此,我们回顾性研究了48例因心源性休克并发急性心肌梗死而接受IABP的初次PCI患者(26例患者在初次PCI前接受IABP, 22例患者在初次PCI后接受IABP)。两组患者的基线临床特征无显著差异。初次PCI前经IABP治疗组的平均病变血管数较多(2.8±0.5 vs 2.3±0.7,P= 0.012),但治疗血管数差异无统计学意义。初次PCI术前接受IABP治疗的患者,肌酸激酶峰值和肌酸激酶- mb水平较低(中位数,1077;四分位数范围438-2067 vs中位数3299;四分位数范围695-6834;P =。047,中位数95;四分位数范围34-196 vs中位数192;四分位数间距为82-467;P =。048年,分别)。在首次PCI术前接受IABP的患者,住院死亡率和主要心脑血管不良事件的总发生率显著降低(19% vs 59%, 23% vs 77%, P=。007, P=。0004年,分别)。多因素分析发现肾衰竭(优势比15.2;95%可信区间,3.13-73.66)和PCI术后置入IABP(优势比,5.2;95%可信区间(1.09-24.76)为院内死亡率的唯一独立预测因子。综上所述,本研究的结果表明,心源性休克合并急性心肌梗死患者在首次PCI辅助下接受IABP的患者比PCI后接受IABP的患者有更有利的住院预后和更低的住院死亡率。Abdel-Wahab M, Saad M, Kynast J,等。心源性休克合并急性心肌梗死的经皮冠状动脉介入治疗前后主动脉内球囊反搏术住院死亡率的比较中华心血管病杂志。2010;25(5):344 - 344。